 | • レポートコード：D0804-01927 • 出版社/出版日：GlobalInfoResearch / 2020年7月21日 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、109ページ • 納品方法：Eメール • 産業分類：医薬品・治療 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、ブクリジンの世界市場を広く調査・分析し、今後の市場展望をまとめております。ブクリジンの種類別市場規模（病院、ドラッグストア）、用途別市場規模（抗アレルギー剤、ヒスタミンH₁受容体拮抗薬）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Stuart Pharmaceuticals、MK Pharma、Mankind Pharma、Laboratorios Rocnarf、Sanofi、UCB、Peili Pharmaceutical、Meider Pharma、Johnson and Johnson、HUA Shin Chemical Pharmaceutical、Pfizer、Sinphar、Al Pharm ・地域別グローバル市場分析 2015年-2020年 ・ブクリジンの北米市場（アメリカ、カナダ、メキシコ） ・ブクリジンのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・ブクリジンのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・ブクリジンの南米市場（ブラジル、アルゼンチン） ・ブクリジンの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：病院、ドラッグストア ・用途別分析：抗アレルギー剤、ヒスタミンH₁受容体拮抗薬 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The Buclizine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The most likely (base case) scenario is that the global Buclizine sales will be xx in 2020 from Buclizine million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global Buclizine market size is expected to grow at xx% or more annually for the next five years.
This report also researches and evaluates the impact of Covid-19 outbreak on the Buclizine industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Buclizine and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).
Market segmentation
Buclizine market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Buclizine market has been segmented into
Hospital
Drug Store
By Application, Buclizine has been segmented into:
Antiallergic Agent
Histamine H₁-Receptor Antagonist
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Buclizine market presented in the report. This section sheds light on the sales growth of different regional and country-level Buclizine markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Buclizine market.
The report offers in-depth assessment of the growth and other aspects of the Buclizine market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Buclizine Market Share Analysis
Buclizine competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Buclizine sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Buclizine sales, revenue and market share for each player covered in this report.
The major players covered in Buclizine are:
Stuart Pharmaceuticals
MK Pharma
Mankind Pharma
Laboratorios Rocnarf
Sanofi
UCB
Peili Pharmaceutical
Meider Pharma
Johnson and Johnson
HUA Shin Chemical Pharmaceutical
Pfizer
Sinphar
Al Pharm
Among other players domestic and global, Buclizine market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Buclizine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Buclizine, with price, sales, revenue and global market share of Buclizine in 2018 and 2019.
Chapter 3, the Buclizine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Buclizine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Buclizine market forecast, by regions, access channel and medical uses, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Buclizine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Buclizine Introduction
1.2 Market Analysis by Access Channel
1.2.1 Overview: Global Buclizine Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Hospital
1.2.3 Drug Store
1.3 Market Analysis by Medical Uses
1.3.1 Overview: Global Buclizine Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Antiallergic Agent
1.3.3 Histamine H₁-Receptor Antagonist
1.4 Overview of Global Buclizine Market
1.4.1 Global Buclizine Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
1.6 COVID-19 Outbreak: Buclizine Industry Impact
1.6.1 COVID-19 Potential Implications for the Buclizine
1.6.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Buclizine
1.6.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.6.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.6.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.6.2 Opportunity Analysis in Covid-19 Crisis
1.6.3 Market Risk and Restraints
1.6.4 Market Driving Force
2 Manufacturers Profiles
2.1 Stuart Pharmaceuticals
2.1.1 Stuart Pharmaceuticals Details
2.1.2 Stuart Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Stuart Pharmaceuticals SWOT Analysis
2.1.4 Stuart Pharmaceuticals Product and Services
2.1.5 Stuart Pharmaceuticals Buclizine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 MK Pharma
2.2.1 MK Pharma Details
2.2.2 MK Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 MK Pharma SWOT Analysis
2.2.4 MK Pharma Product and Services
2.2.5 MK Pharma Buclizine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Mankind Pharma
2.3.1 Mankind Pharma Details
2.3.2 Mankind Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Mankind Pharma SWOT Analysis
2.3.4 Mankind Pharma Product and Services
2.3.5 Mankind Pharma Buclizine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Laboratorios Rocnarf
2.4.1 Laboratorios Rocnarf Details
2.4.2 Laboratorios Rocnarf Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Laboratorios Rocnarf SWOT Analysis
2.4.4 Laboratorios Rocnarf Product and Services
2.4.5 Laboratorios Rocnarf Buclizine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Sanofi
2.5.1 Sanofi Details
2.5.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Sanofi SWOT Analysis
2.5.4 Sanofi Product and Services
2.5.5 Sanofi Buclizine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 UCB
2.6.1 UCB Details
2.6.2 UCB Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 UCB SWOT Analysis
2.6.4 UCB Product and Services
2.6.5 UCB Buclizine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Peili Pharmaceutical
2.7.1 Peili Pharmaceutical Details
2.7.2 Peili Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Peili Pharmaceutical SWOT Analysis
2.7.4 Peili Pharmaceutical Product and Services
2.7.5 Peili Pharmaceutical Buclizine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Meider Pharma
2.8.1 Meider Pharma Details
2.8.2 Meider Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Meider Pharma SWOT Analysis
2.8.4 Meider Pharma Product and Services
2.8.5 Meider Pharma Buclizine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Johnson and Johnson
2.9.1 Johnson and Johnson Details
2.9.2 Johnson and Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Johnson and Johnson SWOT Analysis
2.9.4 Johnson and Johnson Product and Services
2.9.5 Johnson and Johnson Buclizine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 HUA Shin Chemical Pharmaceutical
2.10.1 HUA Shin Chemical Pharmaceutical Details
2.10.2 HUA Shin Chemical Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 HUA Shin Chemical Pharmaceutical SWOT Analysis
2.10.4 HUA Shin Chemical Pharmaceutical Product and Services
2.10.5 HUA Shin Chemical Pharmaceutical Buclizine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Pfizer
2.11.1 Pfizer Details
2.11.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Pfizer SWOT Analysis
2.11.4 Pfizer Product and Services
2.11.5 Pfizer Buclizine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Sinphar
2.12.1 Sinphar Details
2.12.2 Sinphar Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Sinphar SWOT Analysis
2.12.4 Sinphar Product and Services
2.12.5 Sinphar Buclizine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 Al Pharm
2.13.1 Al Pharm Details
2.13.2 Al Pharm Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Al Pharm SWOT Analysis
2.13.4 Al Pharm Product and Services
2.13.5 Al Pharm Buclizine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Buclizine Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Buclizine Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Buclizine Manufacturer Market Share in 2019
3.3.2 Top 6 Buclizine Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Buclizine Sales, Revenue and Market Share by Regions
4.1.1 Global Buclizine Sales and Market Share by Regions (2015-2020)
4.1.2 Global Buclizine Revenue and Market Share by Regions (2015-2020)
4.2 North America Buclizine Sales and Growth Rate (2015-2020)
4.3 Europe Buclizine Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Buclizine Sales and Growth Rate (2015-2020)
4.5 South America Buclizine Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Buclizine Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Buclizine Sales, Revenue and Market Share by Country
5.1.1 North America Buclizine Sales and Market Share by Country (2015-2020)
5.1.2 North America Buclizine Revenue and Market Share by Country (2015-2020)
5.2 United States Buclizine Sales and Growth Rate (2015-2020)
5.3 Canada Buclizine Sales and Growth Rate (2015-2020)
5.4 Mexico Buclizine Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Buclizine Sales, Revenue and Market Share by Country
6.1.1 Europe Buclizine Sales and Market Share by Country (2015-2020)
6.1.2 Europe Buclizine Revenue and Market Share by Country (2015-2020)
6.2 Germany Buclizine Sales and Growth Rate (2015-2020)
6.3 UK Buclizine Sales and Growth Rate (2015-2020)
6.4 France Buclizine Sales and Growth Rate (2015-2020)
6.5 Russia Buclizine Sales and Growth Rate (2015-2020)
6.6 Italy Buclizine Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Buclizine Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Buclizine Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Buclizine Revenue and Market Share by Regions (2015-2020)
7.2 China Buclizine Sales and Growth Rate (2015-2020)
7.3 Japan Buclizine Sales and Growth Rate (2015-2020)
7.4 Korea Buclizine Sales and Growth Rate (2015-2020)
7.5 India Buclizine Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Buclizine Sales and Growth Rate (2015-2020)
7.7 Australia Buclizine Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Buclizine Sales, Revenue and Market Share by Country
8.1.1 South America Buclizine Sales and Market Share by Country (2015-2020)
8.1.2 South America Buclizine Revenue and Market Share by Country (2015-2020)
8.2 Brazil Buclizine Sales and Growth Rate (2015-2020)
8.3 Argentina Buclizine Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Buclizine Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Buclizine Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Buclizine Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Buclizine Sales and Growth Rate (2015-2020)
9.3 Turkey Buclizine Sales and Growth Rate (2015-2020)
9.4 Egypt Buclizine Sales and Growth Rate (2015-2020)
9.5 South Africa Buclizine Sales and Growth Rate (2015-2020)
10 Market Segment by Access Channel
10.1 Global Buclizine Sales and Market Share by Access Channel (2015-2020)
10.2 Global Buclizine Revenue and Market Share by Access Channel (2015-2020)
10.3 Global Buclizine Price by Access Channel (2015-2020)
11 Global Buclizine Market Segment by Medical Uses
11.1 Global Buclizine Sales Market Share by Medical Uses (2015-2020)
11.2 Global Buclizine Revenue Market Share by Medical Uses (2015-2020)
11.3 Global Buclizine Price by Medical Uses (2015-2020)
12 Market Forecast
12.1 Global Buclizine Sales, Revenue and Growth Rate (2021-2025)
12.2 Buclizine Market Forecast by Regions (2021-2025)
12.2.1 North America Buclizine Market Forecast (2021-2025)
12.2.2 Europe Buclizine Market Forecast (2021-2025)
12.2.3 Asia-Pacific Buclizine Market Forecast (2021-2025)
12.2.4 South America Buclizine Market Forecast (2021-2025)
12.2.5 Middle East & Africa Buclizine Market Forecast (2021-2025)
12.3 Buclizine Market Forecast by Access Channel (2021-2025)
12.3.1 Global Buclizine Sales Forecast by Access Channel (2021-2025)
12.3.2 Global Buclizine Market Share Forecast by Access Channel (2021-2025)
12.4 Buclizine Market Forecast by Medical Uses (2021-2025)
12.4.1 Global Buclizine Sales Forecast by Medical Uses (2021-2025)
12.4.2 Global Buclizine Market Share Forecast by Medical Uses (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Buclizine Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Buclizine by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Buclizine Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global Buclizine Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. Stuart Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 9. Stuart Pharmaceuticals Buclizine Major Business
Table 10. Stuart Pharmaceuticals Buclizine Total Revenue (USD Million) (2018-2019)
Table 11. Stuart Pharmaceuticals SWOT Analysis
Table 12. Stuart Pharmaceuticals Buclizine Product and Services
Table 13. Stuart Pharmaceuticals Buclizine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. MK Pharma Basic Information, Manufacturing Base and Competitors
Table 15. MK Pharma Buclizine Major Business
Table 16. MK Pharma Buclizine Total Revenue (USD Million) (2018-2019)
Table 17. MK Pharma SWOT Analysis
Table 18. MK Pharma Buclizine Product and Services
Table 19. MK Pharma Buclizine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. Mankind Pharma Basic Information, Manufacturing Base and Competitors
Table 21. Mankind Pharma Buclizine Major Business
Table 22. Mankind Pharma Buclizine Total Revenue (USD Million) (2018-2019)
Table 23. Mankind Pharma SWOT Analysis
Table 24. Mankind Pharma Buclizine Product and Services
Table 25. Mankind Pharma Buclizine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. Laboratorios Rocnarf Basic Information, Manufacturing Base and Competitors
Table 27. Laboratorios Rocnarf Buclizine Major Business
Table 28. Laboratorios Rocnarf Buclizine Total Revenue (USD Million) (2018-2019)
Table 29. Laboratorios Rocnarf SWOT Analysis
Table 30. Laboratorios Rocnarf Buclizine Product and Services
Table 31. Laboratorios Rocnarf Buclizine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 32. Sanofi Basic Information, Manufacturing Base and Competitors
Table 33. Sanofi Buclizine Major Business
Table 34. Sanofi Buclizine Total Revenue (USD Million) (2018-2019)
Table 35. Sanofi SWOT Analysis
Table 36. Sanofi Buclizine Product and Services
Table 37. Sanofi Buclizine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 38. UCB Basic Information, Manufacturing Base and Competitors
Table 39. UCB Buclizine Major Business
Table 40. UCB Buclizine Total Revenue (USD Million) (2018-2019)
Table 41. UCB SWOT Analysis
Table 42. UCB Buclizine Product and Services
Table 43. UCB Buclizine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 44. Peili Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 45. Peili Pharmaceutical Buclizine Major Business
Table 46. Peili Pharmaceutical Buclizine Total Revenue (USD Million) (2018-2019)
Table 47. Peili Pharmaceutical SWOT Analysis
Table 48. Peili Pharmaceutical Buclizine Product and Services
Table 49. Peili Pharmaceutical Buclizine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 50. Meider Pharma Basic Information, Manufacturing Base and Competitors
Table 51. Meider Pharma Buclizine Major Business
Table 52. Meider Pharma Buclizine Total Revenue (USD Million) (2018-2019)
Table 53. Meider Pharma SWOT Analysis
Table 54. Meider Pharma Buclizine Product and Services
Table 55. Meider Pharma Buclizine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 56. Johnson and Johnson Basic Information, Manufacturing Base and Competitors
Table 57. Johnson and Johnson Buclizine Major Business
Table 58. Johnson and Johnson Buclizine Total Revenue (USD Million) (2018-2019)
Table 59. Johnson and Johnson SWOT Analysis
Table 60. Johnson and Johnson Buclizine Product and Services
Table 61. Johnson and Johnson Buclizine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 62. HUA Shin Chemical Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 63. HUA Shin Chemical Pharmaceutical Buclizine Major Business
Table 64. HUA Shin Chemical Pharmaceutical Buclizine Total Revenue (USD Million) (2018-2019)
Table 65. HUA Shin Chemical Pharmaceutical SWOT Analysis
Table 66. HUA Shin Chemical Pharmaceutical Buclizine Product and Services
Table 67. HUA Shin Chemical Pharmaceutical Buclizine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 68. Pfizer Basic Information, Manufacturing Base and Competitors
Table 69. Pfizer Buclizine Major Business
Table 70. Pfizer Buclizine Total Revenue (USD Million) (2018-2019)
Table 71. Pfizer SWOT Analysis
Table 72. Pfizer Buclizine Product and Services
Table 73. Pfizer Buclizine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 74. Sinphar Basic Information, Manufacturing Base and Competitors
Table 75. Sinphar Buclizine Major Business
Table 76. Sinphar Buclizine Total Revenue (USD Million) (2018-2019)
Table 77. Sinphar SWOT Analysis
Table 78. Sinphar Buclizine Product and Services
Table 79. Sinphar Buclizine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 80. Al Pharm Basic Information, Manufacturing Base and Competitors
Table 81. Al Pharm Buclizine Major Business
Table 82. Al Pharm Buclizine Total Revenue (USD Million) (2018-2019)
Table 83. Al Pharm SWOT Analysis
Table 84. Al Pharm Buclizine Product and Services
Table 85. Al Pharm Buclizine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 86. Global Buclizine Sales by Manufacturer (2018-2019) (K Units)
Table 87. Global Buclizine Revenue by Manufacturer (2018-2019) (USD Million)
Table 88. Global Buclizine Sales by Regions (2015-2020) (K Units)
Table 89. Global Buclizine Sales Market Share by Regions (2015-2020)
Table 90. Global Buclizine Revenue by Regions (2015-2020) (USD Million)
Table 91. North America Buclizine Sales by Countries (2015-2020) (K Units)
Table 92. North America Buclizine Sales Market Share by Countries (2015-2020)
Table 93. North America Buclizine Revenue by Countries (2015-2020) (USD Million)
Table 94. North America Buclizine Revenue Market Share by Countries (2015-2020)
Table 95. Europe Buclizine Sales by Countries (2015-2020) (K Units)
Table 96. Europe Buclizine Sales Market Share by Countries (2015-2020)
Table 97. Europe Buclizine Revenue by Countries (2015-2020) (USD Million)
Table 98. Asia-Pacific Buclizine Sales by Regions (2015-2020) (K Units)
Table 99. Asia-Pacific Buclizine Sales Market Share by Regions (2015-2020)
Table 100. Asia-Pacific Buclizine Revenue by Regions (2015-2020) (USD Million)
Table 101. South America Buclizine Sales by Countries (2015-2020) (K Units)
Table 102. South America Buclizine Sales Market Share by Countries (2015-2020)
Table 103. South America Buclizine Revenue by Countries (2015-2020) (USD Million)
Table 104. South America Buclizine Revenue Market Share by Countries (2015-2020)
Table 105. Middle East & Africa Buclizine Sales by Countries (2015-2020) (K Units)
Table 106. Middle East & Africa Buclizine Sales Market Share by Countries (2015-2020)
Table 107. Middle East & Africa Buclizine Revenue by Countries (2015-2020) (USD Million)
Table 108. Middle East & Africa Buclizine Revenue Market Share by Countries (2015-2020)
Table 109. Global Buclizine Sales by Type (2015-2020) (K Units)
Table 110. Global Buclizine Sales Share by Type (2015-2020)
Table 111. Global Buclizine Revenue by Type (2015-2020) (USD Million)
Table 112. Global Buclizine Revenue Share by Type (2015-2020)
Table 113. Global Buclizine Sales by Application (2015-2020) (K Units)
Table 114. Global Buclizine Sales Share by Application (2015-2020)
Table 115. Global Buclizine Sales Forecast by Regions (2021-2025) (K Units)
Table 116. Global Buclizine Market Share Forecast by Regions (2021-2025)
Table 117. Global Buclizine Sales Forecast by Type (2021-2025) (K Units)
Table 118. Global Buclizine Market Share Forecast by Type (2021-2025)
Table 119. Global Buclizine Sales Forecast by Application (2021-2025)
Table 120. Global Buclizine Market Share Forecast by Application (2021-2025)
Table 121. Direct Channel Pros & Cons
Table 122. Indirect Channel Pros & Cons
Table 123. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Buclizine Picture
Figure 2. Global Sales Market Share of Buclizine by Access Channel in 2019
Figure 3. Hospital Picture
Figure 4. Drug Store Picture
Figure 5. Buclizine Sales Market Share by Medical Uses in 2018
Figure 6. Antiallergic Agent Picture
Figure 7. Histamine H₁-Receptor Antagonist Picture
Figure 8. Global Buclizine Market Status and Outlook (2015-2025) (USD Million)
Figure 9. United States Buclizine Revenue (Value) and Growth Rate (2015-2025)
Figure 10. Canada Buclizine Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Mexico Buclizine Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Germany Buclizine Revenue (Value) and Growth Rate (2015-2025)
Figure 13. France Buclizine Revenue (Value) and Growth Rate (2015-2025)
Figure 14. UK Buclizine Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Russia Buclizine Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Italy Buclizine Revenue (Value) and Growth Rate (2015-2025)
Figure 17. China Buclizine Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Japan Buclizine Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Korea Buclizine Revenue (Value) and Growth Rate (2015-2025)
Figure 20. India Buclizine Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Southeast Asia Buclizine Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Australia Buclizine Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 23. Brazil Buclizine Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Egypt Buclizine Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Saudi Arabia Buclizine Revenue (Value) and Growth Rate (2015-2025)
Figure 26. South Africa Buclizine Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Turkey Buclizine Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Global Buclizine Sales Market Share by Manufacturer in 2019
Figure 29. Global Buclizine Revenue Market Share by Manufacturer in 2019
Figure 30. Top 3 Buclizine Manufacturer (Revenue) Market Share in 2019
Figure 31. Top 6 Buclizine Manufacturer (Revenue) Market Share in 2019
Figure 32. Key Manufacturer Market Share Trend
Figure 33. Global Buclizine Sales and Growth Rate (2015-2020) (K Units)
Figure 34. Global Buclizine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 35. Global Buclizine Revenue Market Share by Regions (2015-2020)
Figure 36. Global Buclizine Revenue Market Share by Regions in 2018
Figure 37. North America Buclizine Sales and Growth Rate (2015-2020)
Figure 38. Europe Buclizine Sales and Growth Rate (2015-2020)
Figure 39. Asia-Pacific Buclizine Sales and Growth Rate (2015-2020)
Figure 40. South America Buclizine Sales and Growth Rate (2015-2020)
Figure 41. Middle East & Africa Buclizine Sales and Growth Rate (2015-2020)
Figure 42. North America Buclizine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 43. North America Buclizine Sales Market Share by Countries (2015-2020)
Figure 44. North America Buclizine Sales Market Share by Countries in 2018
Figure 45. North America Buclizine Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 46. North America Buclizine Revenue Market Share by Countries in 2018
Figure 47. United States Buclizine Sales and Growth Rate (2015-2020) (K Units)
Figure 48. Canada Buclizine Sales and Growth Rate (2015-2020) (K Units)
Figure 49. Mexico Buclizine Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Europe Buclizine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 51. Europe Buclizine Revenue Market Share by Countries (2015-2020)
Figure 52. Europe Buclizine Revenue Market Share by Countries in 2019
Figure 53. Germany Buclizine Sales and Growth Rate (2015-2020) (K Units)
Figure 54. UK Buclizine Sales and Growth Rate (2015-2020) (K Units)
Figure 55. France Buclizine Sales and Growth Rate (2015-2020) (K Units)
Figure 56. Russia Buclizine Sales and Growth Rate (2015-2020) (K Units)
Figure 57. Italy Buclizine Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Asia-Pacific Buclizine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 59. Asia-Pacific Buclizine Sales Market Share by Regions 2019
Figure 60. Asia-Pacific Buclizine Revenue Market Share by Regions 2019
Figure 61. China Buclizine Sales and Growth Rate (2015-2020) (K Units)
Figure 62. Japan Buclizine Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Korea Buclizine Sales and Growth Rate (2015-2020) (K Units)
Figure 64. India Buclizine Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Southeast Asia Buclizine Sales and Growth Rate (2015-2020) (K Units)
Figure 66. South America Buclizine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 67. South America Buclizine Sales Market Share by Countries in 2019
Figure 68. South America Buclizine Revenue Market Share by Countries in 2019
Figure 69. Brazil Buclizine Sales and Growth Rate (2015-2020) (K Units)
Figure 70. Argentina Buclizine Sales and Growth Rate (2015-2020) (K Units)
Figure 71. Middle East and Africa Buclizine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 72. Middle East and Africa Buclizine Sales Market Share by Countries in 2019
Figure 73. Middle East and Africa Buclizine Revenue Market Share by Countries (2015-2020)
Figure 74. Middle East and Africa Buclizine Revenue Market Share by Countries in 2019
Figure 75. Saudi Arabia Buclizine Sales and Growth Rate (2015-2020) (K Units)
Figure 76. Egypt Buclizine Sales and Growth Rate (2015-2020) (K Units)
Figure 77. Turkey Buclizine Sales and Growth Rate (2015-2020) (K Units)
Figure 78. South Africa Buclizine Sales and Growth Rate (2015-2020) (K Units)
Figure 79. Global Buclizine Sales and Growth Rate (2021-2025) (K Units)
Figure 80. Global Buclizine Revenue and Growth Rate (2021-2025) (USD Million)
Figure 81. North America Sales Buclizine Market Forecast (2021-2025) (K Units)
Figure 82. Europe Sales Buclizine Market Forecast (2021-2025) (K Units)
Figure 83. Asia-Pacific Sales Buclizine Market Forecast (2021-2025) (K Units)
Figure 84. South America Sales Buclizine Market Forecast (2021-2025) (K Units)
Figure 85. Middle East & Africa Sales Buclizine Market Forecast (2021-2025) (K Units)
Figure 86. Sales Channel: Direct Channel vs Indirect Channel
スフィンゴシン1-リン酸受容体1の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The Sphingosine 1-Phosphate Receptor 1 market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain …- ピゾチフェンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The Pizotifen market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regul…
- スフィンゴシン-1-受容体調節薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The Sphingosine-1-Receptor Modulators Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value c…
- AT1受容体拮抗薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global AT1 Receptor Antagonists market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The AT1 Receptor Antagon…
- AT1受容体拮抗薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global AT1 Receptor Antagonists market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The AT1 Receptor Antagon…